NICE issues draft guidance on solriamfetol for treating excessive daytime sleepiness caused by narcolepsy

In DRAFT guidance, NICE does not recommend solriamfetol for treating excessive daytime sleepiness in adults with narcolepsy with or without cataplexy. Cost-effectiveness estimates are uncertain and very likely to be higher than what NICE normally considers acceptable.

Source:

National Institute for Health and Care Excellence